Juglone as an inhibitor of Pin1 was evaluated in MCT-Shunt model of PAH, which demonstrates endothelial dysfunction, vascular remodelling, and neointimal formation similarly to human PAH. This evidence concerns the gene PIN1 and endothelial dysfunction.